CC
VANI icon

Centiva Capital’s Vivani Medical VANI Stock Holding History

Centiva Capital’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,506
Closed -$12.3K – 1866
2022
Q4 		$12.3K Buy
+14,506
New +$23.6K ﹤0.01% 1293

Other funds holding VANI

TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Centiva Capital's VANI Position: Q1 2023 in Review

Centiva Capital sold out of Vivani Medical (VANI) in Q1 2023, closing a stake of 14,506 shares — an estimated $12.3K sold.

Centiva Capital first reported a position in VANI in Q4 2022 and held it in 1 quarter. The position peaked at $12.3K in Q4 2022. 33 funds tracked by Wall St. Rank hold VANI as of Q1 2023.

  • Centiva Capital reported no remaining Vivani Medical position as of Q1 2023 after selling out during the quarter.
  • Centiva Capital sold 14,506 Vivani Medical shares in Q1 2023, an estimated $12.3K.
  • Centiva Capital first reported a position in Vivani Medical in Q4 2022 and held it in 1 quarter.
  • Centiva Capital's Vivani Medical position peaked at $12.3K in Q4 2022.
  • 33 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2023.

Based on Centiva Capital's 13F filing for Q1 2023, filed 15 May 2023.